Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

September 20, 2024

Study Completion Date

October 31, 2024

Conditions
Drug-Induced Movement Disorder
Interventions
OTHER

Telemedicine Consult

Neurological consultation completed remotely

OTHER

In-person Consult

Neurological consultation completed in-person

Trial Locations (1)

05401

University of Vermont Medical Center, Burlington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Neurocrine Biosciences

INDUSTRY

lead

University of Vermont

OTHER